Repeat Systemic Delivery of Cross-Neutralization Resistant Synthetic Vesiculoviruses Immunomodulates the Tumor Microenvironment
Natalie M. Elliott, Benjamin Luke Kendall, Souyma Dutta, Daipayan Sarkar, John Vant, Jill Thompson, Elizabeth A. Raupach, Christopher Shin, Khandoker Usran Ferdous, Aleksandra Cios, Kenneth H. Buetow, Chelsae R Watters, SangKon Oh, Autumn J. Schulze, Alex T Baker, , Mitesh J. Borad
A glycoprotein-engineered vesiculovirus platform circumvents neutralizing antibodies, enabling repeat intravenous dosing and sustained anti-tumor immunity in preclinical models.
bioRxiv · Aug 1, 2025 · PreprintMolecular Biology